URGN EPS Estimates
UroGen Pharma Ltd.
$35.01
+$0.86(+2.52%)
48
Overall
40
Value
45
Tech
60
Quality
Market Cap
$1.71B
Volume
739.96K
52W Range
$16.37 - $50.81
Target Price
$57.67
URGN EPS estimates: the consensus estimate for UroGen Pharma Ltd.'s current fiscal year is -$0.20 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
URGN EPS Estimates
- EPS estimate, current quarter
- $0.38
- EPS estimate, next quarter
- $0.06
- EPS estimate, current year
- $-0.20
- EPS estimate, next year
- $3.20
- EPS growth, 3-year
- +12.79%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.19 |
| 2024 | $-2.96 |
| 2023 | $-3.55 |
| 2022 | $-4.81 |
| 2021 | $-4.96 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $35.01 | +2.5% | 739.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |